Usefulness of Exhaled Nitric Oxide to Guide Risk Stratification for Bronchiolitis Obliterans Syndrome After Lung Transplantation

Autor: Neurohr, C. ^*, Huppmann, P., Leuschner, S., von Wulffen, W., Meis, T., Leuchte, H., Ihle, F., Zimmermann, G., Baezner, C., Hatz, R., Winter, H., Frey, L., Ueberfuhr, P., Bittmann, I., Behr, J.

Publikováno v: In American Journal of Transplantation January 2011 11(1):129-137

Omalizumab Rescue Therapy for Refractory Status Asthmaticus.

Autor: Milger K; Ludwig-Maximilians-University of Munich and Comprehensive Pneumology Center, Munich, Germany (K.M., J.B., N.K.)., Schroeder I; Ludwig-Maximilians-University of Munich, Munich, Germany (I.S.)., Behr J; Ludwig-Maximilians-University of Munich and Comprehensive Pneumology Center, Munich, Germany (K.M., J.B., N.K.)., Meis T; Klinik Augustinum München, Munich, Germany (T.M., W.V.W.)., Wulffen WV; Klinik Augustinum München, Munich, Germany (T.M., W.V.W.)., Kneidinger N; Ludwig-Maximilians-University of Munich and Comprehensive Pneumology Center, Munich, Germany (K.M., J.B., N.K.).

Publikováno v: Annals of internal medicine [Ann Intern Med] 2019 Mar 05; Vol. 170 (5), pp. 351-352. Date of Electronic Publication: 2018 Nov 20.

(653) - Influence of Pantoprazole Dosages on Azole Plasma Concentrations in Lung Transplant Recipients

Autor: Stelzer, D., Ihle, F., Weber, A., Kneidinger, N., Meis, T., Zimmermann, G., Schramm, R., Winter, H., Frey, L., Vogeser, M., Andraschko, M., Behr, J., Neurohr, C.

Publikováno v: In Journal of Heart and Lung Transplantation April 2015 34(4) Supplement:S241-S242

Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative—Group 3 Pulmonary Hypertension

Autor: Shlobin, Oksana A.¹ (AUTHOR) oksana.shlobin@inova.org, Shen, Eric² (AUTHOR), Wort, Stephen J.³ (AUTHOR), Piccari, Lucilla⁴ (AUTHOR), Scandurra, John A.⁵ (AUTHOR), Hassoun, Paul M.⁶ (AUTHOR), Nikkho, Sylvia M.⁷ (AUTHOR), Nathan, Steven D.¹ (AUTHOR)

Publikováno v: Pulmonary Circulation. Jan2024, Vol. 14 Issue 1, p1-17. 17p.

Augmentation of the effects of vasoactive intestinal peptide aerosol on pulmonary hypertension via coapplication of a neutral endopeptidase 24.11 inhibitor.

Autor: Leuchte HH; Department of Internal Medicine V, Ludwig Maximilians University, Klinikum Grosshadern, Munich, Germany; Department of Internal Medicine II, Neuwittelsbach Hospital, Munich, Germany; hanno.leuchte@lmu.de., Prechtl C; Department of Internal Medicine V, Ludwig Maximilians University, Klinikum Grosshadern, Munich, Germany;, Callegari J; Department of Internal Medicine V, Ludwig Maximilians University, Klinikum Grosshadern, Munich, Germany;, Meis T; Department of Internal Medicine V, Ludwig Maximilians University, Klinikum Grosshadern, Munich, Germany;, Haziraj S; Department of Internal Medicine V, Ludwig Maximilians University, Klinikum Grosshadern, Munich, Germany;, Bevec D; Department of Internal Medicine II, Neuwittelsbach Hospital, Munich, Germany; Therametrics Group, Thalwil, Switzerland., Behr J; Department of Internal Medicine V, Ludwig Maximilians University, Klinikum Grosshadern, Munich, Germany;

Publikováno v: American journal of physiology. Lung cellular and molecular physiology [Am J Physiol Lung Cell Mol Physiol] 2015 Mar 15; Vol. 308 (6), pp. L563-8. Date of Electronic Publication: 2015 Jan 16.